These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1864302

  • 21. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
    Gundlach AL, Christie MJ, Beart PM.
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
    [Abstract] [Full Text] [Related]

  • 22. The effects of a long term dihydroergotoxine treatment on agonist and antagonist striatal dopamine binding sites are dose and age related.
    Ferretti C, Blengio M, Eva C, Ghi P, Bosco MC, Portaleone P.
    Pharmacol Res Commun; 1986 Oct; 18(10):967-78. PubMed ID: 3809237
    [Abstract] [Full Text] [Related]

  • 23. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E, Bohmaker K, Goldstein M, Schweitzer JW, Friedhoff AJ.
    Eur J Pharmacol; 1985 Mar 12; 109(3):389-94. PubMed ID: 3157587
    [Abstract] [Full Text] [Related]

  • 24. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
    Bhargava HN.
    Gen Pharmacol; 1983 Mar 12; 14(6):609-14. PubMed ID: 6141122
    [Abstract] [Full Text] [Related]

  • 25. Effect of nicotine pretreatment on striatal dopaminergic system in rats.
    Fung YK, Lau YS.
    Pharmacol Biochem Behav; 1989 Jan 12; 32(1):221-6. PubMed ID: 2734333
    [Abstract] [Full Text] [Related]

  • 26. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
    Battaini F, Govoni S, Rius RA, Spano PF, Trabucchi M.
    Pharmacol Res Commun; 1984 Jun 12; 16(6):605-11. PubMed ID: 6463097
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC, Givens BS, Schulz DW, Bunney BS, Breese GR, Mailman RB.
    J Pharmacol Exp Ther; 1986 Mar 12; 236(3):838-45. PubMed ID: 3512819
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Mar 12; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lateralization of neocortical dopamine receptors and dopamine level in normal Wistar rats.
    Nowak G.
    Pol J Pharmacol Pharm; 1989 Mar 12; 41(2):133-7. PubMed ID: 2687822
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
    Valchár M, Vrsecká M, Krejcí I, Dlabac A.
    Eur J Pharmacol; 1987 Apr 07; 136(1):97-101. PubMed ID: 3297739
    [Abstract] [Full Text] [Related]

  • 40. Decrease in the number of rat brain dopamine and muscarinic receptors after chronic alcohol intake.
    Syvälahti EK, Hietala J, Röyttä M, Grönroos J.
    Pharmacol Toxicol; 1988 Apr 07; 62(4):210-2. PubMed ID: 3387375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.